IFM Investors Pty Ltd Has $2.28 Million Position in Humana Inc (HUM)

Share on StockTwits

IFM Investors Pty Ltd increased its stake in Humana Inc (NYSE:HUM) by 10.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 7,945 shares of the insurance provider’s stock after purchasing an additional 725 shares during the quarter. IFM Investors Pty Ltd’s holdings in Humana were worth $2,276,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of HUM. Moody National Bank Trust Division acquired a new position in shares of Humana during the fourth quarter worth approximately $30,000. FNY Investment Advisers LLC acquired a new position in shares of Humana during the fourth quarter worth approximately $57,000. Matthew Goff Investment Advisor LLC acquired a new position in shares of Humana during the third quarter worth approximately $64,000. IMS Capital Management acquired a new position in shares of Humana during the third quarter worth approximately $68,000. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Humana by 24.6% during the fourth quarter. Quadrant Capital Group LLC now owns 365 shares of the insurance provider’s stock worth $92,000 after buying an additional 72 shares during the last quarter. Hedge funds and other institutional investors own 92.72% of the company’s stock.

In other Humana news, insider Heidi S. Margulis sold 2,656 shares of the company’s stock in a transaction on Tuesday, December 18th. The stock was sold at an average price of $296.22, for a total value of $786,760.32. Following the sale, the insider now directly owns 10,371 shares in the company, valued at $3,072,097.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David A. Jr/Ky Jones sold 600 shares of the company’s stock in a transaction on Saturday, November 16th. The shares were sold at an average price of $88.05, for a total value of $52,830.00. The disclosure for this sale can be found here. Insiders sold 9,078 shares of company stock worth $2,570,350 over the last quarter. Company insiders own 0.60% of the company’s stock.

A number of research analysts have recently commented on HUM shares. Morgan Stanley upped their price target on Humana from $400.00 to $418.00 and gave the stock a “buy” rating in a report on Thursday, November 8th. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $377.00 price target for the company in a report on Thursday, October 4th. JPMorgan Chase & Co. upgraded Humana from a “neutral” rating to an “overweight” rating and set a $283.00 price target for the company in a report on Thursday, December 20th. Bank of America upped their price target on Humana from $400.00 to $415.00 and gave the stock a “buy” rating in a report on Thursday, November 8th. Finally, Royal Bank of Canada upped their price target on Humana from $318.00 to $349.00 and gave the stock a “sector perform” rating in a report on Thursday, November 8th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $348.85.

Shares of HUM traded up $0.43 on Wednesday, reaching $299.21. 40,336 shares of the stock traded hands, compared to its average volume of 884,652. The stock has a market cap of $40.55 billion, a PE ratio of 25.56, a P/E/G ratio of 1.15 and a beta of 1.09. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.45. Humana Inc has a 12 month low of $260.00 and a 12 month high of $355.88.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 7th. The insurance provider reported $4.58 earnings per share for the quarter, beating analysts’ consensus estimates of $4.29 by $0.29. Humana had a return on equity of 19.10% and a net margin of 2.70%. The firm had revenue of $14.21 billion for the quarter, compared to analysts’ expectations of $13.97 billion. During the same period in the prior year, the business posted $3.39 earnings per share. Equities analysts forecast that Humana Inc will post 14.42 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 25th. Shareholders of record on Monday, December 31st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Friday, December 28th. Humana’s dividend payout ratio (DPR) is 8.54%.

TRADEMARK VIOLATION WARNING: “IFM Investors Pty Ltd Has $2.28 Million Position in Humana Inc (HUM)” was published by Zolmax and is the property of of Zolmax. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://zolmax.com/investing/ifm-investors-pty-ltd-has-2-28-million-position-in-humana-inc-hum/2844541.html.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Recommended Story: How to Use the New Google Finance Tool

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Dolby Laboratories, Inc.  Major Shareholder Dagmar Dolby Sells 69,885 Shares of Stock
Dolby Laboratories, Inc. Major Shareholder Dagmar Dolby Sells 69,885 Shares of Stock
Raymond James Lowers Alamos Gold  to Market Perform
Raymond James Lowers Alamos Gold to Market Perform
Fidelity National Information Servcs Inc  CEO Gary Norcross Sells 88,016 Shares of Stock
Fidelity National Information Servcs Inc CEO Gary Norcross Sells 88,016 Shares of Stock
Zacks: Brokerages Set $30.50 Price Target for TTEC Holdings Inc
Zacks: Brokerages Set $30.50 Price Target for TTEC Holdings Inc
American Hotel Income Properties REIT LP  Given Average Rating of “Buy” by Analysts
American Hotel Income Properties REIT LP Given Average Rating of “Buy” by Analysts
Altice USA  Posts  Earnings Results, Beats Estimates By $0.20 EPS
Altice USA Posts Earnings Results, Beats Estimates By $0.20 EPS


Leave a Reply

 
© 2006-2019 Zolmax.